Jose E. Almeida
Net Worth

Last updated:

What is Jose E. Almeida net worth?

The estimated net worth of Mr. Jose E. Almeida is at least $12,613,974 as of 23 May 2016. He owns shares worth $283,974 as insider and has received compensation worth at least $12,330,000 in Baxter International Inc..

What is the salary of Jose E. Almeida?

Mr. Jose E. Almeida salary is $1,370,000 per year as Chairman, Pres & Chief Executive Officer in Baxter International Inc..

How old is Jose E. Almeida?

Mr. Jose E. Almeida is 63 years old, born in 1962.

What stocks does Jose E. Almeida currently own?

As insider, Mr. Jose E. Almeida owns shares in one company:

Company Title Shares Price per share Total value
Baxter International Inc. (BAX) Chairman, Pres & Chief Executive Officer 11,691 $24.29 $283,974

What does Baxter International Inc. do?

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Jose E. Almeida insider trading

Baxter International Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock, $1 par value 11,691 $42.75 $499,790

Baxter International key executives

Baxter International Inc. executives and other stock owners filed with the SEC: